Multi-Project Video Production Services
ID: 357852Type: Posted
Overview

Buyer

National Institute of Corrections (USDOJ-BOP-NIC)

Award Range

$0 - $200K

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Cooperative Agreement

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357852
Timeline
    Description

    The National Institute of Corrections (NIC) is offering a cooperative agreement for Multi-Project Video Production Services, aimed at supporting various ongoing NIC projects. This opportunity is not a request for applications but rather a continuation of funding for cooperative agreement award 22CS27GLM1, which emphasizes the importance of professional video production in enhancing NIC's initiatives. The total estimated program funding is $200,000, with a single award expected, and interested parties can reach out to Grant Management Specialist Cameron D. Coblentz at ccoblentz@bop.gov or by phone at 202-514-0053 for further information. The application period will remain open until January 20, 2025.

    Point(s) of Contact
    ccoblentz@bop.gov
    Files
    No associated files provided.
    Similar Opportunities
    National Community Anti-Drug Coalition Institute (NCI)
    Active
    Office of National Drug Control Policy
    The Office of National Drug Control Policy (ONDCP) is forecasting a grant opportunity titled the National Community Anti-Drug Coalition Institute (NCI), aimed at enhancing the capacity of community coalitions to implement evidence-based substance use prevention interventions. The primary objectives of this grant are to increase the effectiveness of community coalitions across the United States and to strengthen the technical assistance and training provided to these coalitions, particularly during the critical adolescent years when substance use initiation is most prevalent. With an estimated total program funding of $2.5 million and a single award anticipated, eligible applicants include national nonprofit organizations with expertise in community anti-drug coalitions. Interested parties should note that the estimated synopsis post date is December 9, 2024, with a closing date for applications on February 7, 2025, and the expected award date is March 10, 2025. For further inquiries, applicants can contact Helen Hernandez, Assistant Director for Drug Free Communities, at HelenHernandez@ondcp.eop.gov or by phone at 202-395-6665.
    Notice of Intent to Publish a Funding Opportunity Announcement for Single Source: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Centers (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a funding opportunity announcement for a cooperative agreement aimed at establishing a Network Radiotherapy and Imaging Core Services Center under the NCI National Clinical Trials Network (NCTN). This center will provide essential scientific and technical expertise for quality control, assurance, and image data management in NCTN trials that involve radiotherapy and imaging modalities, as well as support for other NCI-supported clinical trial programs. The funding opportunity is significant for enhancing cancer treatment research and is expected to have a total program funding of $8.8 million, with a ceiling of $8.14 million for the award. Interested private institutions of higher education should prepare their applications, as the anticipated application due date is in late February 2025, with an estimated award date set for March 1, 2026.
    Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), has announced the Innovation Corps (I-Corps) at NIH Program, aimed at enhancing the commercialization of biomedical innovations from Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I projects. This program provides administrative supplement awards to eligible small business concerns, facilitating entrepreneurship training and assisting teams in refining their commercialization strategies through customer discovery activities over an eight-week course. With a total funding pool of up to $2.64 million available for up to 48 awards, individual grants are capped at $55,000, and applications must be submitted by January 31, 2025. Interested applicants are encouraged to contact NIH Grants Information at grantsinfo@nih.gov for further guidance before applying.
    Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network (NCTN) - Network Group Operations Centers, which will require a U10 clinical trial. This initiative aims to provide scientific leadership for the development and implementation of multi-disciplinary, multi-institutional clinical trials targeting various cancer types and populations, focusing on late-phase treatment trials and advanced imaging studies. The funding, estimated at $99.3 million, is intended to support the conduct of essential clinical research for adults, adolescents, and children with cancer, with the NOFO expected to be published in Fall 2024 and applications due by late February 2025. For further details, applicants should prepare their submissions in advance of the anticipated award date of March 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for a single-source grant aimed at establishing the NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network. This initiative seeks to partner with private institutions of higher education to conduct large-scale, multi-site clinical trials, focusing on late-phase treatment trials and advanced imaging across various cancer types, while ensuring regulatory oversight in Canada. The funding, estimated at $3.8 million, is intended to support the NCTN's efforts to enhance clinical research for diverse patient populations, with the application due in late February 2025 and the award anticipated by March 1, 2026. Interested applicants should prepare their proposals in advance of the expected NOFO publication in Fall 2024.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The total estimated program funding is $2 million, with an award ceiling of $850,000 and an expected two awards to be made. The Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2024, with applications due in late February 2025, and awards expected to be announced by March 1, 2026. Interested applicants should prepare their proposals accordingly.
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications for diverse preclinical and clinical projects that can expedite the FDA approval process for new treatments, addressing the significant public health need for effective therapies for conditions such as cocaine, methamphetamine, and cannabis use disorders. The program will provide cooperative agreements for projects lasting up to three years, with annual budgets capped at $5 million, and applications are accepted on a rolling basis with specific due dates for scientific merit review established throughout 2023 and 2024. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-202.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network, specifically targeting Network Lead Academic Participating Sites through a cooperative agreement. The primary objective is to provide scientific leadership in developing and conducting multi-center clinical trials for various cancer treatments, contributing to substantial patient accrual across the NCTN. This initiative is crucial for advancing clinical research and improving treatment options for diverse patient populations affected by cancer. The estimated total program funding is $35,100,000, with an award ceiling of $1,700,000 and approximately 35 awards expected. Interested applicants should prepare for the anticipated application due date in late February 2025, following the NOFO publication in Fall 2024.
    NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)" to support the development and dissemination of vital bioinformatics resources related to embryonic developmental processes. The primary objective of this funding opportunity is to ensure the ongoing operation, maintenance, and enhancement of unique database resources that are crucial for biomedical research utilizing animal models, while promoting user training, data curation, and interoperability with other NIH bioinformatics tools. This initiative is significant for advancing research in the field and adheres to FAIR data principles, with funding amounts ranging from $500,000 to $1,750,000 annually for a maximum project period of five years. Interested applicants should note that the application submission deadlines begin on December 25, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional) to support research on effective interventions for individuals with substance use disorders (SUDs) within the criminal-legal system. This initiative aims to enhance the delivery of medication for opioid use disorder (MOUD) and address the overdose crisis by establishing multiple research centers that will collaborate with resource centers to improve treatment access and continuity of care for justice-involved populations. With a total funding budget of $5 million, the NIH plans to award five to seven grants, each with a maximum direct cost of $2.25 million, for projects lasting up to five years. Interested applicants must submit their proposals by January 22, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.